Načítá se...
Effect of time and titer in convalescent plasma therapy for COVID-19
The clinical benefit of convalescent plasma (CP) for patients with coronavirus disease (COVID)-19 is still debated. In this systematic review and meta-analysis, we selected 10 randomized clinical trials (RCTs) and 15 non-randomized studies (total number of patients = 22,591) of CP treatment and eval...
Uloženo v:
| Vydáno v: | iScience |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8297982/ https://ncbi.nlm.nih.gov/pubmed/34316549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.isci.2021.102898 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|